Enovis Corp Ordinary Shares ENOV 深 沪
等待开盘 09-05 09:30:00 美东时间
31.55
+0.890
+2.90%
华盛通- 最 高31.60
- 今 开30.45
- 成交量 91.75万股
- 最 低 30.00
- 昨 收 30.66
- 总市值 18.02亿
- 52周最高 49.83
- 市盈率 静 --
- 换手率 1.61%
- 52周最低 25.465
- 委 比 95.00%
- 总股本 5712.31万
- 历史最高 176.11
- 量 比 0.86
- 振 幅 5.22%
- 历史最低 -13.31
- 每 手 1
- 风险率 6.49%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Independent Testing Confirms Enovix AI-1™ Battery as Industry’s Highest Energy Density Smartphone Battery
Enovix AI-1TM smartphone battery achieves record-breaking energy density and fast charging, validated by Polaris Battery Labs. Capable of 919 Wh/L and 3C fast charging, Enovix targets the multi-billion-dollar smartphone market with advanced silicon battery technology, positioning itself as a leader in high-performance energy storage solutions.
08-27 12:30
Enovix Appoints Veteran Semiconductor Leader J. Daniel “Dan” McCranie to its Board of Directors
Enovix Corporation appoints J. Daniel "Dan" McCranie to its Board of Directors, expanding the Board to eight members, six of whom are independent. McCranie, with over three decades of experience in public-company governance and leadership in the semiconductor and technology sectors, brings significant expertise to Enovix. His strategic insights will support the company's commercialization and manufacturing expansion. McCranie has held senior role...
08-14 12:52
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $41
Wells Fargo analyst Vik Chopra maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $48 to $41.
08-08 23:21
Enovis shares are trading higher after the company reported better-than-expected Q2 financial results and raised FY25 outlook.
Enovis shares are trading higher after the company reported better-than-expecte...
08-07 18:49
Enovis Raises FY2025 Adj EPS Guidance from $2.95-$3.10 to $3.05-$3.20 vs $3.03 Est; Raises FY2025 Sales Guidance from $2.220B-$2.250B to $2.245B-$2.275B vs $2.236B Est
2025 Financial OutlookEnovis updated financial expectations for 2025. Revenue is expected to be in the range of $2.245-2.275 billion, versus prior expectations of $2.220-2.250 billion. Adjusted EBITDA is forecasted to be
08-07 18:04
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Enovix Shareholder Reminder: Early Warrant Expiration Price Condition
Enovix Corporation announced that its common stock price has exceeded $10.50 for 9 consecutive trading days since the distribution of warrants (ENVXW). The warrants remain $1.96 in-the-money with an exercise price of $8.75. The earliest expiration date is August 19, 2025, contingent on the stock trading above $10.50 for 20 of 30 trading days. CFO Ryan Benton noted that only 11 trading days may remain before expiration, encouraging shareholders to...
08-01 20:59
Enovix Chairman TJ Rodgers Issues Letter to Shareholders on Warrant Dividend
<p>Enovix Corporation has distributed a letter from Chairman TJ Rodgers to all shareholders regarding the Company’s recent warrant dividend distribution. The letter is available on the Company’s website. For more details on the warrants, including exercise mechanics and terms, refer to SEC filings and information on the Company’s website. Enovix is a leader in advanced lithium-ion battery technology, focusing on silicon-anode batteries that provi...
07-29 12:30
Enovix Distributes Dividend of Warrants to Stockholders
<p>Enovix Corporation announced it will distribute warrants to purchase common stock to its shareholders and certain convertible noteholders on July 21, 2025. Shareholders of record as of July 17, 2025, will receive one warrant for every seven shares held, rounded down. Warrants are exercisable for cash and expire on October 1, 2026. An early expiration may occur if the VWAP of Enovix stock equals or exceeds $10.50 for 20 out of 30 consecutive tr...
07-21 12:45
